News
The latest publication from the lab of Department of Bioengineering and Therapeutic Sciences professor and Vice Dean of Research Tanja Kortemme, PhD, along with a $1.4 million award from the National Science Foundation, recognizes major possibilities and support for her vision of integrating AI and molecular design to advance health and sustainability.
James Fraser Honored with Carl Brändén Award from The Protein Society
The Department of Bioengineering and Therapeutic Sciences chair was honored for pioneering advances in room-temperature X-ray data collection techniques and ensemble modeling methods, which have enabled deeper understanding and engineering of proteins. He has also been a champion of collaborative, project-based learning and has advocated for greater accessibility in scientific publishing.
Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2?
Powerful drug candidates perform better than Paxlovid against SARS-CoV-2 and could head off future coronavirus pandemics. The research, from a team at UCSF and Gladstone Institutes that includes School of Pharmacy researchers, has stalled since the grant was cut.
Bridging borders in science: Q&A with Einstein Visiting Fellow Nevan Krogan, PhD
The Department of Bioengineering and Therapeutic Sciences professor will lead a new global research initiative with Freie Universität Berlin, establishing a Berlin-based lab to advancing cross-border collaboration and innovation in structural biology, infectious disease and therapeutic discovery.
Full Circle Symposium Brings Together Native and Indigenous Scientists
Led by Department of Bioengineering and Therapeutic Sciences Assistant Professor Willow Coyote-Maestas, PhD, MS, and presented by the school’s Quantitative Biosciences Institute (QBI), the symposium — which is open to all — aims to build a thriving community for Native and Indigenous scientists in academia.
Koda-Kimble Seed Award Fuels 11 Innovative Projects in 2025
Eleven innovative projects with the potential to further the mission of the UCSF School of Pharmacy in new ways will garner a financial boost from the 2025 Mary Anne Koda-Kimble Seed Award for Innovation.
Kortemme awarded International Feodor Lynen Medal from the German Society for Biochemistry and Molecular Biology
The school’s vice dean of research received the award at an annual event that fosters scientific exchange among experts in biochemistry and molecular biology, where she delivered a lecture that delved into her work on the creation of novel proteins and their applications in engineering molecular and cellular functions.
Decoding COVID-19: QBI Researchers Pave the Way for New Drug Discoveries to Combat Virus
The QBI Coronavirus Research Group (QCRG) fast-tracked antiviral drug discovery by partnering with scientists around the globe and around the clock, deepening understanding of how viruses attack cells and shaping the future of pandemic preparedness.
Lessons Learned: Five Years of COVID-19 Research and Response at UCSF
UCSF School of Pharmacy experts share their perspectives on the lessons learned from the pandemic and the evolving role of pharmacy in strengthening public health, advancing scientific discovery and preparing for future global challenges.
UCSF Scientists Discover How Hungry Fat Cells Could Someday Starve Cancer to Death
Department of Bioengineering and Therapeutic Sciences professor Nadav Ahituv is part of a team of researchers using the gene editing technology CRISPR to deprive tumors of nutrition.
Year in Review: Top 5 Milestones of 2024
Here are some of the standout moments from 2024 that drove our commitment to leadership in research, education, patient care, and innovation, all aimed at expanding knowledge and enhancing health worldwide.
School of Pharmacy faculty recognized among Highly Cited Researchers
The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the school’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.
New Master of Science Program is Leading Transformational Change in Drug Discovery and Drug Development
The first program of its kind in the United States, the MS in AICD3 is enabling its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.
UCSF School of Pharmacy Leads $30M Award to Speed Drug Development with AI
The Department of Bioengineering and Therapeutic Sciences (BTS) chair is leading a multidisciplinary team that will receive federal funding to prevent side effects before drugs go to clinical trials.
Ahituv selected for American Society of Human Genetics Scientific Achievement Award
The director of the UCSF Institute for Human Genetics (IHG) is being recognized for his lab’s work investigating gene regulatory elements––their relationship to human diversity and disease and their utilization for gene therapy.
School of Pharmacy celebrates global drug development and regulatory science collaboration
June 14, 2024, marked the 15-year collaboration of a Chinese course improving medical product development and regulation.